Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.75 - $5.6 $225,217 - $1.68 Million
-300,290 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.3 - $7.28 $387,796 - $855,501
117,514 Added 64.29%
300,290 $1.59 Million
Q4 2021

Feb 14, 2022

BUY
$4.6 - $10.21 $530,214 - $1.18 Million
115,264 Added 170.73%
182,776 $932,000
Q3 2021

Nov 15, 2021

BUY
$6.59 - $38.71 $444,904 - $2.61 Million
67,512 New
67,512 $454,000

Others Institutions Holding EAR

About Eargo, Inc.


  • Ticker EAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 39,411,000
  • Market Cap $2.78B
  • Description
  • Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...
More about EAR
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.